These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33257207)

  • 1. The use of anti-obesity medications in people with mental illness as an adjunct to lifestyle interventions - Effectiveness, tolerability and impact on eating behaviours: A 52-week observational study.
    Tham M; Chong TWH; Jenkins ZM; Castle DJ
    Obes Res Clin Pract; 2021; 15(1):49-57. PubMed ID: 33257207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an online cognitive behavioural therapy weight loss programme as an adjunct to anti-obesity medications and lifestyle interventions.
    Tham M; Chong TW
    Australas Psychiatry; 2020 Apr; 28(2):140-147. PubMed ID: 31523974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.
    Czepiel KS; Perez NP; Campoverde Reyes KJ; Sabharwal S; Stanford FC
    Front Endocrinol (Lausanne); 2020; 11():290. PubMed ID: 32477270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.
    Shibuya K; Ali KF; Ji X; Milinoivh A; Bauman J; Kattan MW; Pantalone KM; Burguera B
    Endocr Pract; 2019 Oct; 25(10):1022-1028. PubMed ID: 31241358
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.
    Pantalone KM; Smolarz BG; Ramasamy A; Baz Hecht M; Harty BJ; Rogen B; Griebeler ML; Borukh E; Young JB; Burguera B
    JAMA Netw Open; 2021 Jul; 4(7):e2116595. PubMed ID: 34255049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and predictors of response to topiramate plus lifestyle modification in youth with obesity seen in a weight management clinical setting.
    Bomberg EM; Clark J; Rudser KD; Gross AC; Kelly AS; Fox CK
    Front Endocrinol (Lausanne); 2024; 15():1369270. PubMed ID: 38800488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK.
    Wilding JPH
    Clin Obes; 2018 Jun; 8(3):211-225. PubMed ID: 29689646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychoeducation for overweight patients with psychiatric disorders: The Wellness program developed in Quebec].
    Provencher MD; Bélanger MÈ; Shriqui C; Lachance I; Bonneville S
    Encephale; 2016 Jun; 42(3):201-7. PubMed ID: 26924000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.
    Cates ME; Feldman JM; Boggs AA; Woolley TW; Whaley NP
    Ann Pharmacother; 2008 Apr; 42(4):505-10. PubMed ID: 18364406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
    Kiortsis DN
    Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing comorbid obesity and depression through clinical pharmacotherapies.
    McElroy SL; Guerdjikova AI; Mori N; Keck PE
    Expert Opin Pharmacother; 2016 Aug; 17(12):1599-610. PubMed ID: 27280311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral treatment of obesity in patients taking antipsychotic medications.
    Kalarchian MA; Marcus MD; Levine MD; Haas GL; Greeno CG; Weissfeld LA; Qin L
    J Clin Psychiatry; 2005 Aug; 66(8):1058-63. PubMed ID: 16086623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes associated with anti-obesity medications in real-world practice: A systematic literature review.
    Ahmad NN; Robinson S; Kennedy-Martin T; Poon JL; Kan H
    Obes Rev; 2021 Nov; 22(11):e13326. PubMed ID: 34423889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.
    Weintraub MA; D'Angelo D; Tchang BG; Sahagun AD; Andre C; Aronne LJ; Shukla AP
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e832-e841. PubMed ID: 36810608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on pharmacotherapeutic strategies for obesity.
    Tchang BG; Tarazi MS; Aras M; Shukla AP
    Expert Opin Pharmacother; 2021 Jul; 22(10):1305-1318. PubMed ID: 33599159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.